Skip to product information
1 of 1

ChemForge

Retatrutide, 10mg

Retatrutide, 10mg

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
Shipping calculated at checkout.
Retatrutide is an investigational once-weekly injectable triple-hormone receptor agonist developed by Eli Lilly and Company. It targets GLP-1, GIP, and glucagon receptors, showing up to 28% average body weight loss in Phase 3 trials, though it is not yet FDA-approved and carries risks when sourced from the black market.
How Retatrutide Works
  • GLP-1 Receptor Activation: Slows stomach emptying, suppresses appetite, and aids in blood sugar control. 
  • GIP Receptor Activation: Enhances insulin secretion and works synergistically with the GLP-1 pathway. 
  • Glucagon Receptor Activation: Increases resting energy expenditure and stimulates the liver to burn stored fat.
View full details